Medicen Paris Region

What Medicen Paris Region does

Medicen Paris Region is a non-profit competitiveness cluster ("pôle de compétitivité") and Association loi 1901 founded in 2005 and headquartered at 130 rue Lourmel, 75015 Paris, that orchestrates the health-innovation ecosystem of the Île-de-France region. It curates a 450-member community spanning 370 SMEs and startups, 42 mid-sized and large corporate groups (ETIs/grands groupes), and 35 academic and clinical research institutions, with a stated mission to identify partners, secure funding and accelerate growth for member health-innovation projects. The cluster has labelled 1,459 collaborative R&D projects, of which more than 500 have been financed, generating approximately €2.4 billion of investment and bringing 110+ health products to market over the past two decades.

Its service offering is organised around three operational pillars. First, project labelling and training labelling: the official "labellisation" mechanism certifies collaborative health R&D projects, unlocking access to public funding, while a separate programme labels initial and continuing education curricula in healthtech (18 programmes and 4 "health initiatives" labelled in 2023). Second, growth and acceleration programmes, including the Scale-Up Booster (a seven-month HealthTech accelerator structured around diagnostic, roadmap co-construction and partner mobilisation), Bio2JUMP (bioproduction and biotherapy accelerator launched November 2023), Med4You, Mentor4you, Hi France, and the BOOST TechSanté cohort with CCI Val-de-Marne, Sanofi, GPSEA and DRIEETS. Third, intelligence, events and media: the annual Medi'Scope barometer co-produced with Ayming (positioning Île-de-France as Europe's #1 region for private health funding, with €2.7B invested 2021-2023), flagship events such as Chirurgie 4.0 (formerly Chirurgie du Futur, gathering 400+ clinicians and industrials), REGMED Europe, Medicen Day and the Microbiota working group, the L'Écho Santé podcast launched May 2025, and the members-only My Medicen extranet.

Medicen's revenue model combines annual membership fees (paid "adhésion" under the Grille de cotisations 2026, indexed to member type and size and conditional on signing the Charter of Ethics), public funding tied to its Phase V "pôle de compétitivité" designation by the French Ministry of Economy (granted March 2023), EU and national programme budgets (Programme des Investissements d'Avenir, Bpifrance, FEDER, Horizon Europe, COSME, Interreg NWE), and event sponsorship and programme partnerships (e.g., Medtronic France and Fujifilm as Platinum sponsors of Chirurgie du Futur). Its 2025-2027 strategic roadmap, unveiled at its 20th anniversary in March 2025, targets making Île-de-France the leading European health innovation ecosystem by 2027, leveraging the Enosis Santé alliance (1,200 members, €5B+ in R&D projects) and a portfolio of EU-coordinator and EU-partner roles in projects such as Health InnoFacilitator, STEP4NAMs, BIO-RED and Codex4SMEs.

Name

Medicen Paris Region

Legal name

MEDICEN PARIS REGION

Website

https://medicen.org

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Medicen Paris Region is a non-profit health innovation competitiveness cluster (pôle de compétitivité) serving 450+ members in Île-de-France through R&D project labelling, acceleration programmes, public funding access, and ecosystem events.

Ownership category

akta.pro rank

Product category

Health innovation cluster services

NAICS

Social Advocacy Organizations (8133), Grantmaking Foundations (813211)

SIC

Services-Membership Organizations (8600), Services-Social Services (8300)

akta.pro primary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

akta.pro secondary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

Keywords

• Health innovation cluster
• R&D project labelling
• Biotech accelerator programs
• Medtech ecosystem networking
• Competitiveness cluster services

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership fees: Annual paid membership ('cotisation annuelle') per the Grille de cotisations 2026 fee schedule. Membership is approved by the Executive Bureau and contingent on signing the Charter of Ethics and Charter of Engagement; the fee depends on the type and size of the member organization (grand groupe, start-up/TPE/PME/ETI, academic, healthcare institution, training body, territorial authority).
2. Public funding and labelling-related grants: Public funding channelled through state-backed labelling programs (e.g., Phase V labelling by the French Ministry of Economy in 2023) and public investment programs such as Programme des Investissements d'Avenir, Bpifrance, EU funds (FEDER, Horizon Europe, COSME, SMP, Interreg NWE). Medicen itself is a non-profit association (Association loi 1901).
3. Event sponsorship and program partnerships: Sponsorship of flagship events such as Chirurgie du Futur (Platinum sponsors e.g., Medtronic France, Fujifilm) and partner-funded programs (Scale-Up Booster, Bio2JUMP, Med4You, Mentor4you, BOOST TechSanté). Sponsor revenue and program co-funding supplement membership and public funds.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels10 records

Core offering

Medicen Paris Region is a non-profit health innovation competitiveness cluster (Association loi 1901) that curates and animates a 450-member ecosystem in Île-de-France comprising SMEs, startups, large groups, academic researchers and clinicians. Its core services are official labelling of collaborative R&D projects to unlock public funding, paid annual membership with diagnostic, networking and growth-program benefits, accelerators and mentoring programs (Scale-Up Booster, Bio2JUMP, Med4You, Mentor4you, Hi France, BOOST TechSanté), training labelling, and flagship events (Chirurgie 4.0, REGMED Europe, Medicen Day, Medi'Scope barometer, L'Écho Santé podcast).

Differentiator

Problem solved

Functional benefit

Products and services

• Annual Medicen Membership

Quantifiable outcome

• 450+ active members in the Île-de-France health innovation network
• +9 more outcomes

Named customers21 records

Segments6 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

23 partnerships are on record, tiered minor, core and flagship.

• Medshake StudiominorGTM or Marketing Partner · 1 May 2025Studio partner for the production of L'Écho Santé, Medicen's new podcast launched in May 2025 at the time of the cluster's 20-year anniversary.
• Femtech FrancecoreStrategic or Co-development Partner · 1 January 2025Strategic partnership signed in January 2025 between Medicen Paris Region and Femtech France to offer exclusive benefits to innovative companies in women's health. Enables co-membership with preferential tariffs to both organizations. Day-to-day contact: Pauline Poccioni (Responsable filière Innovation – Santé Numérique & Données de Santé at Medicen).
• Académie Nationale de ChirurgiecoreStrategic or Co-development Partner · 1 November 2024Co-organizer of the 'Chirurgie 4.0' (formerly 'Chirurgie du Futur') annual event. 2nd edition took place 28–29 November 2024, gathering 400+ clinicians, industrials, academics and institutional actors. Themes: connected surgical robotics, planning, infrastructure, data. Also partnered with CNJC, Enosis Santé, and the alliance of BioValley France, Eurobiomed, Lyonbiopole.
• AymingcoreImplementation/ SI/ Consulting Partner · 1 October 2024Co-produces the Medi'Scope annual barometer of health innovation in Île-de-France (3rd edition launched 1 October 2024 at Medicen Day). Joint press release and downloadable PDF publication.
• France BiotechminorGTM or Marketing Partner · 1 February 2024Medicen (via Enosis Santé) supports the Trophées de la HealthTech 2024 organized by France Biotech; jury co-chaired by Lise Alter (Agence de l'Innovation en Santé) and Audrey Derveloy (Sanofi France). Winners announced 25 March 2024 at Théâtre de la Tour Eiffel.
• SpartnersminorGTM or Marketing Partner · 1 January 2024Co-launcher of the Bio Partnering Pass Challenge (January 2024) selecting a delegation of 5 companies to attend BIO USA 2024 in San Diego (3–6 June 2024). Winners received a partnership pass.
• CCI Val-de-Marne (BOOST TechSanté program)minorGTM or Marketing Partner · 1 January 2024Medicen is an engaged partner of BOOST TechSanté launched January 17, 2024 at CCI Val-de-Marne; supports 10 biotech/medtech/e-health SMEs over 8 months via diagnostic 360 and connections to Grand Paris Sud Est Avenir, Sanofi, and DRIEETS Île-de-France.
• BIO-RED consortium (11 partners, 7 EU countries)coreStrategic or Co-development Partner · 1 January 2024Medicen participates as a French partner in BIO-RED (Building Interregional Opportunities for Digital and Green Innovation in Red Biotechnology and Pharmaceuticals), an EU-funded project with 11 partners across 7 EU countries (Denmark, Portugal, Greece, Lithuania, Bulgaria, France, Sweden) mapping regional ecosystems and developing a strategic interregional roadmap.
• STEP4NAMs consortium (10 partners, 6 nationalities; BioRegio STERN lead)coreStrategic or Co-development Partner · 1 January 2024Medicen is a partner in the 48-month STEP4NAMs project (Interreg NWE, €6,332,365.47 budget, €3,799,419.27 FEDER grant). Focuses on New Approach Methodologies (NAMs) — Organ-on-Chip, Organoids, Digital Twin, Bioprinting — as alternatives to animal experimentation. Consortium partners include BioRegio STERN, BOM, InnovationQuarter, Eurasanté, flanders.bio, 3R-Center Tübingen, ATU Galway, University of Galway, Université du Luxembourg.
• Health InnoFacilitator consortium (coordinated by Medicen)flagshipStrategic or Co-development Partner · 1 January 2024EU-funded project coordinated by Medicen Paris Region to build the InnoFacilitator community connecting public buyers and innovative solution providers (SMEs/startups) to foster innovation procurement (PPI). Partners include BioIndustry Park Silvia Fumero (BICPCA), EUREGHA, HOPE, RESAH, SILO, and EHPPA.
• France Healthtech (Panorama)minorGTM or Marketing Partner · 1 October 2023Medicen is a partner of the Panorama France Healthtech 2023 (October 2023) — co-promotion of the French healthtech ecosystem panorama.
• AIS (Alliance Innovation Santé) and Enosis SantécoreStrategic or Co-development Partner · 1 July 2023Partnership signed July 2023 between AIS and Enosis Santé to accelerate the implementation of Plan Innovation Santé 2030 and multiply cluster actions closer to the territories.
• BioMan4R2 consortium (BIOCAT lead, SMP COSME)coreStrategic or Co-development Partner · 1 January 2023EU SMP COSME project providing financial support and networking to SMEs in biomanufacturing and medical technologies. Medicen partner with BIOCAT, Turku Science Park, BioRegio Stern, GAPR, LifetecZONe.
• Medtronic France and Fujifilm (Chirurgie du Futur 2022 Platinum sponsors)minorGTM or Marketing Partner · 1 September 2022Platinum sponsors of the 2nd edition of Chirurgie du Futur (20 October 2022, Hôpital Américain de Paris); Medtronic France ran an exclusive workshop on surgeon/industry collaboration.
• INNAXE consortium (Biocat lead, 6 clusters incl. CEBR)coreStrategic or Co-development Partner · 1 July 202224-month Horizon Europe EIE project (July 2022–June 2024) coordinated by Biocat, Catalonia; Medicen is a partner with BioRN, HLSC Bulgaria, Danish Life Science Cluster, and CEBR. Aims to strengthen interconnection and innovation capacity among European life-science/health-tech clusters, producing a joint action plan and white paper.
• Enosis Santé (BioValley France, Eurobiomed, Lyonbiopôle Auvergne-Rhône-Alpes, Medicen)flagshipStrategic or Co-development Partner · 1 May 2022Alliance of France's four main health competitiveness clusters announced May 2022 (formalized July 2023 with AIS-Enosis partnership). Enosis Santé represents 1,200 members (over 1,000 innovative TPE/PME), 1,000+ R&D projects, €5B+ investment, 230+ products/services on market, and €1.3B raised by member companies in 2021. Coordinates implementation of Plan Innovation Santé 2030 across regions.
• OTECI (association)minorImplementation/ SI/ Consulting Partner · 1 March 2022Partner association for the Mentor4you program (launched March 2022): three training modules (KOL/data generation, partnership strategy, value proposition) for health startups. Sessions priced at €300 (Découverte) or €600 (Application).
• EIT Health FrancecoreGTM or Marketing Partner · 1 February 2022Partnership renewed February 2022 to promote EIT Health acceleration programs 2022 to Medicen SMEs, startups and entrepreneurs. Enables European exposure and access to EIT Health's expert network. Quotes from Jessica Leygues (DG Medicen) and Jean-Marc Bourez (DG EIT Health France).
• AFSSIminorStrategic or Co-development Partner · 1 February 2022Cross-referenced reaffirmation of the AFSSI-Medicen 2021 partnership in early 2022, with AFSSI presenting its members and expertise at a Medicen biotech-pharma commission dedicated to immuno-oncology.
• EIT Health SCI FI consortiumminorStrategic or Co-development Partner · 1 January 20223-month hybrid training program (Sept–Dec) coordinated by Medical University of Lodz to transition researchers from academia to industry (Pharma/MedTech). Industrial partners include Boehringer Ingelheim, Roche, Novartis, Deloitte; academic partners include Maastricht University, University of Galway, FAU Erlangen, IBEC, BIST, CRG, IRB Barcelona, Institut Mines-Télécom (IMT).
• AFSSI (Association Française des Sociétés de Services et d'Innovation en Sciences de la Vie)minorStrategic or Co-development Partner · 1 April 2021Convention de partenariat signed April 2021 to strengthen synergies: joint thematic events, joint organization of AFSSI Connexions in Île-de-France, and cross-membership scheme between AFSSI and Medicen.
• Codex4SMEs consortium (9 partners, 6 countries)coreStrategic or Co-development Partner · 1 January 2018Interreg NWE project to accelerate personalized medicine by supporting ~200 SMEs in companion diagnostics (Cdx). Medicen is a partner alongside flanders.bio, EATRIS, IBBL, InnovationQuarter, WestBIC, BOM, BioRegio STERN (Germany, France, Netherlands, Ireland, Luxembourg, Belgium). 46 SMEs targeted to increase TRL by one level and at least 4 to develop a full new product.
• BONE project consortium (Interreg NWE, Maastricht University lead)minorStrategic or Co-development Partner · 1 January 20175-year Interreg NWE project on Bio-fabrication of Orthopaedics in a New Era (BONE), coordinated by Maastricht University with 4 research institutes, 4 business support structures, and 5 industrial actors. Focuses on Melt ElectroWriting (MEW) 3D implants for bone regeneration. Terminated in 2022 with REGMED Europe (3 June 2022, Paris) reviewing outcomes.

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Eurobiomed: Competitiveness cluster for healthtech and biotech in the Provence-Alpes-Côte d'Azur and Occitanie regions, co-founded Enosis Santé with Medicen. Directly comparable scope (R&D labelling, accelerator programs, ecosystem animation) and target member profile (SMEs, large groups, academics).
• BioValley France: French competitiveness cluster focused on health innovation in the Grand Est region, co-founded Enosis Santé alongside Medicen. Directly comparable as a 'pôle de compétitivité' offering labelling, programs and networking to members in the same national cluster ecosystem.
• Biocat: Catalonia's life sciences and healthtech cluster; coordinated the INNAXE and BioMan4R2 EU projects alongside Medicen. Directly comparable as a regional life-sciences cluster providing services (acceleration, internationalization, training) to member companies.
• Lyonbiopôle Auvergne-Rhône-Alpes: Health competitiveness cluster covering Auvergne-Rhône-Alpes, co-founder of Enosis Santé. Directly comparable as a regional health innovation cluster with labelling, accelerator programs (e.g., Bio2JUMP-like initiatives) and member services structurally similar to Medicen's.
• BioRegio STERN: German life-sciences cluster coordinating STEP4NAMs and BONE alongside Medicen. Directly comparable as a regional health/biotech cluster with EU project activity, R&D labelling and SME acceleration programs.
• flanders.bio: Flemish life-sciences cluster, partner with Medicen on Codex4SMEs and STEP4NAMs. Comparable in mission (life-sciences ecosystem building, SME support, EU project participation) and member composition (SMEs, large pharma, academics).

Emerging players

• Femtech France: French association for women's-health technology, entered a strategic partnership with Medicen in January 2025 offering co-membership. Comparable as a thematic health-innovation community, but narrower (women's health only) and smaller scale than Medicen.
• AFSSI: French association of life-sciences services and innovation companies; cross-membership partnership with Medicen since 2021. Comparable as an ecosystem organizer serving CROs and service providers in life sciences, with overlapping but narrower scope than Medicen.

Broad incumbents

• France Biotech: French association of healthtech entrepreneurs and investors. Comparable as a national health-innovation ecosystem body, but its focus is venture-stage advocacy and the HealthTech Trophées rather than regional R&D labelling and project certification.
• EIT Health France: European knowledge and innovation community for health, partnered with Medicen since 2022. Comparable as an ecosystem orchestrator providing acceleration programs and EU reach to health SMEs, but operating pan-European rather than regionally and with different funding mechanics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCIa57zgrwbUANnzzA5vjo1g
• Xx.com/pole_medicen
• LinkedInlinkedin.com/company/medicen-paris-region

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medicen Paris Region